Detalhe da pesquisa
1.
USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Circulation
; 149(9): 684-706, 2024 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994595
2.
HINT2 protects against pressure overload-induced cardiac remodelling through mitochondrial pathways.
J Cell Mol Med
; 28(8): e18276, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546629
3.
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD+-SIRT3 pathway.
Acta Pharmacol Sin
; 45(6): 1175-1188, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459256
4.
Salidroside ameliorates pathological cardiac hypertrophy via TLR4-TAK1-dependent signaling.
Phytother Res
; 37(5): 1839-1849, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512326
5.
Neutrophil degranulation and myocardial infarction.
Cell Commun Signal
; 20(1): 50, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410418
6.
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
Acta Pharmacol Sin
; 43(8): 1989-2002, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916609
7.
Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.
Acta Pharmacol Sin
; 43(10): 2562-2572, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948751
8.
TMEM173 protects against pressure overload-induced cardiac hypertrophy by modulating autophagy.
J Cell Physiol
; 236(7): 5176-5192, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368294
9.
Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism.
Cell Biol Toxicol
; 37(6): 873-890, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469864
10.
Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.
Acta Pharmacol Sin
; 42(9): 1390-1400, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214697
11.
Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice.
Acta Pharmacol Sin
; 42(4): 573-584, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694761
12.
6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
Acta Pharmacol Sin
; 42(10): 1575-1586, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462378
13.
TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy.
J Cell Mol Med
; 24(18): 10913-10923, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140921
14.
Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure.
J Pharmacol Sci
; 143(3): 199-208, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414690
15.
Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
J Cell Mol Med
; 23(9): 6466-6478, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31293067
16.
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
J Cell Mol Med
; 23(8): 5715-5727, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31225721
17.
Galangin ameliorates cardiac remodeling via the MEK1/2-ERK1/2 and PI3K-AKT pathways.
J Cell Physiol
; 234(9): 15654-15667, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741414
18.
Galangin ameliorates cardiac remodeling via the MEK1/2-ERK1/2 and PI3K-AKT pathways.
J Cell Physiol
; 239(2): e31208, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310614
19.
Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs.
Mediators Inflamm
; 2019: 6168340, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31686985
20.
CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1.
J Mol Cell Cardiol
; 114: 38-47, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061338